570 - Hi, We would like to highlight specific market data for our brand. We seem to fall into the guidelines that PAAB has put together but the specific data we would like to highlight is the new patient share (this consists of naive and switch patients). It would be a "leader" or "#1" claim. This data is from the private payer database (RxDynamics). Is this type of data allowable? I've done leader market claims as it relates to the total prescriptions dispensed but have never tried this type of data. Thank you.
-
Modified August 20, 2019: The RxDynamics provides a measure of patient longitudinal drug utilization within a particular market. As it tracks utilization on a patient level, it captures whether a patient is new to a drug (within the analyzed window). For example, the dataset can be considered for claims like “#1 dispensed [drug category e.g. PDE5 Inhibitor] as initial therapy”. Make sure the data & claim relate to a drug category (not a disease) per the following guidance:
www.paab.ca/Retention_and_market_share_claims.pdf
Also note that the requirements relating to “leader” type claims from the marketshare supplementary guidance apply as to all other PAAB code provisions (for example, switch messages are often incomplete and overly selective).
Also note that we’ve received submissions which aimed to support this sort of claim with NRx data from the GPM (Geographic Prescription Monitor) database. This is not acceptable.
Trademark acknowledgement: RxDynamics and GPM are trademarks of IMShealth|Brogan
